The incidence and impact of lupus anticoagulants among patients in the intensive care unit.
Aldawood
Abdulaziz S
AS
Department of Critical Care, King Fahad Hospital, PO Box 1149, Riyadh 11322, Kingdom of Saudi Arabia. aldawooda@ hotmail.com
Crowther
Mark
M
Jaeschke
Roman
R
Dabbagh
Ousama
O
Alkhairy
Khalid
K
Baharoon
Salim
S
Ahmed
Nazir
N
D016022:Case-Control Studies; D002423:Cause of Death; D015331:Cohort Studies; D003422:Critical Care; D016638:Critical Illness / Q000401:mortality*; D004363:Drug Utilization; D005260:Female; D006801:Humans; D015994:Incidence; D007362:Intensive Care Units; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008297:Male; D010314:Partial Thromboplastin Time; D011336:Probability; D012016:Reference Values; D018570:Risk Assessment; D016019:Survival Analysis
D016682:Lupus Coagulation Inhibitor